Hello QUIT participants, CPhA’s has published a new edition of Patient Self Care (PSC) since the last edition in 2002. I would like to highlight that one of your QUIT experts Kristine Petrasko is the author of the chapter on smoking cessation. Since the last edition in 2002, several improvements and additions were made. [...]
Hello QUIT participants,
CPhA’s has published a new edition of Patient Self Care (PSC) since the last edition in 2002.
I would like to highlight that one of your QUIT experts Kristine Petrasko is the author of the chapter on smoking cessation.
Since the last edition in 2002, several improvements and additions were made. For example, Varenicline (Champix®) approved by Health Canada in 2007 was added to PSC and has shown higher quit rates compared to other available agents.
This chapter does an excellent job outlines various aspects of smoking cessation including:
- pathiophysiology
- prevalence
- health risks
- patient assessment
- goals of therapy
- nonpharmacologic therapy
- pharmacologic therapy
- special considerations
- monitoring of therapy
Questions:
- Have you read the latest edition of PSC? What do you think?
- What do you think about the chapter on smoking cessation?
- Is there anything you think is missing and should be added to this chapter?
- What have you found is the best resource for community pharmacists helping patients quit smoking?
Please feel free to leave your comments and promote discussion!
3 Responses
I’d also like to add that since the PSC was launched earlier this year, CPhA has started incuding these sample chapters in the QUIT training CD’s that all QUIT program participants receive.
The chapter author is Kristine Petrasko, one of our author-moderators here on the forum, and one of the facilitators of the live QUIT training sessions.
Heather Hough Reply:
December 10th, 2010 at 7:20 am
Hmm. I see that Peter already noted that Kristiine was the author of this chapter. I also see that I can’t go back and edit mey comment. An idea for the future!
I’m just testing the email feed. If all goes well, I should get an update in my email that a new comment has been published. Any other subscribers may ignore this message.